Formulation development and characterization of fast disintegrating tablets of Nimesulide

Authors

  • Manoj M Nitalikar Department of Pharmaceutics, Shri Vithal Education and Research Institute?s College of Pharmacy, Pandharpur Dist., Solapur
  • Dinesh M Sakarkar Department of Pharmaceutics, S. N. Institute of Pharmacy, Pusad Dist., Yavatmal,

DOI:

https://doi.org/10.3329/sjps.v4i2.10436

Keywords:

Formulation, characterization, fast disintegrating, tablet, nimesulide

Abstract

An attempt was made to prepare fast dissolving tablets of anti-inflammatory drug Nimesulide preparing by direct compression method. The superdisintegrants Cross-carmellose and Sodium starch glycolate were used in different concentrations. Twelve formulations using those superdisintegrants at different concentration levels were prepared to access their efficiency and critical concentration level. Different evaluation parameters for tablet were studied. Tablets containing Cross-carmellose showed superior organoleptic properties and excellent in-vitro drug release as compared to other formulations. It was observed that on increasing the concentration of Cross-carmellose, the rate of disintegration was increased whereas on increasing the concentration of Sodium starch glycolate the rate of disintegration was decreased. The percentage drug release was observed as 96.32% when the concentration of Cross-carmellose was increased, whereas the same was not observed on increasing the concentration of Sodium starch glycolate.

DOI: http://dx.doi.org/10.3329/sjps.v4i2.10436

S. J. Pharm. Sci. 4(2) 2011: 25-28

Downloads

Download data is not yet available.
Abstract
1248
PDF
1875

Downloads

Published

2012-04-21

How to Cite

Nitalikar, M. M., & Sakarkar, D. M. (2012). Formulation development and characterization of fast disintegrating tablets of Nimesulide. Stamford Journal of Pharmaceutical Sciences, 4(2), 25–28. https://doi.org/10.3329/sjps.v4i2.10436

Issue

Vol. 4 No. 2 (2011)

Section

Research Articles

License

As a condition of publication, all authors must transfer copyright to the Department of Pharmacy. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission, and that the final version of the manuscript has been seen and approved by them.

Each author must agree to this statement

Authorship: This manuscript is the original work of the authors, each of whom has read and approved of the work. Each author satisfied the requirements contained in 'Author Guidelines' having participated sufficiently in the work to take public responsibility for the content. This participation includes:

  • Conception or design of the study, or analysis and interpretation of data, or both
  • Drafting the article or revising it for critically important intellectual content
  • Approval of the final 'to be published' version

All authors must take responsibility for the integrity of the work. Participating solely in the collection of data does not justify authorship.

Prior publication: This work is not currently under consideration by any other journal. Information about prior publication of any part of this work, or inclusion of patients detailed herein in any other work, has been provided in the cover letter.

Conflict of interest: Details of any financial or other relationship between any author and any other party that may lead to a conflict of interest with the subject or any materials mentioned in this article have been disclosed in the cover letter.